Promises
1 promise
Promise Tracker
0 delivered, 0 close, 1 missed.
View Promises →Emmvee Photovoltaic Power Ltd — Q4 FY26
Emmvee delivered a stellar FY26 with revenue of ₹5,049 crore (+116% YoY), EBITDA of ₹1,734 crore (+140% YoY), and PAT of ₹1,082 crore (+193% YoY).
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Emmvee delivered a stellar FY26 with revenue of ₹5,049 crore (+116% YoY), EBITDA of ₹1,734 crore (+140% YoY), and PAT of ₹1,082 crore (+193% YoY). EBITDA margin expanded 300 bps to 34%, driven by scale benefits, operating leverage, and first full year of cell operations. Module capacity reached 10.3 GW, cell capacity 2.94 GW, with cell utilization improving to 69.9% (79% in Q4). Order book doubled to 9.4 GW, with strong inflows. The company is executing a 6 GW integrated cell and module facility (module line by end CY26, cell line by end FY27) and plans a 9 GW wafer facility in phases starting FY29. Balance sheet strengthened post-IPO with net debt/equity at -0.06x. Key risk: potential delay in ALMM enforcement could shift DCR/non-DCR mix, though management sees minimal impact.
Promises0 met · 1 missedRisks4 trackedTranscriptfull text
Research workspace
Focused Modules
Risks
4 risks
Risk Intelligence
Potential delay in ALMM enforcement
View Risks →
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Module Production
2,999 MW
+102% YoY
Module production doubled to 2,999 MW in FY26 from 1,482 MW in FY25.
Cell Production
1,520 MW
+185% YoY
Cell production nearly tripled to 1,520 MW in FY26 from 534 MW in FY25.
Cell Capacity Utilization
69.9%
+26.6pp YoY
Cell utilization improved from 43.3% in FY25 to 69.9% in FY26, reaching 79% in Q4.
Order Book
9.4 GW
+92% YoY
Order book increased from 4.9 GW in FY25 to 9.4 GW in FY26, with Q4 inflow of 1.27 GW.
What Changed vs Last Quarter
NEW
6 GW integrated cell and module facility commissioning timeline
Module line to be commissioned by end of calendar year 2026, cell line by end of financial year 2027.
NEW
Wafer facility plan of 9 GW in phases
Phase 1 of 5 GW wafer facility to be set up in FY29 (calendar year 2028), with phase 2 of 4 GW a year later.
NEW
Cell utilization to sustain around 80-85%
Management expects cell utilization to remain at similar levels, having achieved 85% in some months.
NEW
DCR mix to increase to near 100% by end of FY27
As ALMM2 takes effect, management expects all capacity sold to be DCR-compliant by early next fiscal.
DROPPED
EBITDA margin sustainability at ~35%
Management expects to maintain current EBITDA margin levels, supported by pass-through contracts and cost efficiencies.
DROPPED
Silver paste consumption reduction of 40%
Further 40% reduction in silver paste consumption per cell targeted through process improvements.
DROPPED
Cell capacity expansion to 8.9 GW by FY28
Planned integrated cell and module facility at Junali will add 6 GW cell capacity, taking total to 8.9 GW by FY28.
NEW RISK
Potential delay in ALMM enforcement
Some developers have petitioned to push the ALMM deadline to July; a delay could shift DCR/non-DCR mix, though management sees minimal impact.
NEW RISK
Working capital build-up
Inventory and receivables have increased significantly, with changes in finished goods inventory of ₹636 crore. Management expects normalization but this could pressure cash flows.
NEW RISK
Commodity and logistics volatility
Management noted that freight rules, commodity cycles, and logistics may remain volatile, impacting costs.
NEW RISK
Execution risk on large capex plans
The 6 GW integrated facility and 9 GW wafer plant require significant capital (₹4,800 crore for the former). Any delays or cost overruns could impact returns.
RISK GONE
Oversupply of domestic cell capacity
India's cell capacity may reach 140 GW by FY28, potentially leading to pricing pressure and lower utilization for less efficient players.
RISK GONE
Grid connectivity delays for utility projects
Delays in transmission infrastructure could push back project timelines and module offtake, though management sees no abnormal delays currently.
RISK GONE
Rising raw material costs (silver, aluminum)
Silver prices have more than doubled recently; while management claims pass-through and efficiency gains, sustained increases could pressure margins.
Fast read
Guidance and risk preview
Module line to be commissioned by end of calendar year 2026, cell line by end of financial year 2027.
Some developers have petitioned to push the ALMM deadline to July; a delay could shift DCR/non-DCR mix, though management sees minimal impact.
View Risks →